 | Up a level |
Ainscough, LP, Ford, JL, Morecroft, CW, Peak, M 
ORCID: 0000-0003-1909-3211, Turner, MA ORCID: 0000-0002-5299-8656, Nunn, AJ and Roberts, M
(2018)
Accuracy of intravenous and enteral preparations involving small volumes for paediatric use: a review.
EUROPEAN JOURNAL OF HOSPITAL PHARMACY, 25 (2).
pp. 66-71.
Bracken, L, Nunn, A, Kirkham, JJ ORCID: 0000-0003-2579-9325, Peak, M ORCID: 0000-0003-1909-3211, Arnott, J, Smyth, RL, Pirmohamed, M ORCID: 0000-0002-7534-7266 and Turner, M ORCID: 0000-0002-5299-8656
(2017)
Development of the Liverpool Adverse Drug Reaction Avoidability Assessment Tool.
PLoS ONE, 12 (1).
e0169393-.
Sherratt, F ORCID: 0000-0003-4147-9305, Roper, L, Baildam, E, Peak, M ORCID: 0000-0003-1909-3211, McErlane, F, Stones, S and Young, B
(2017)
Family perspectives on the feasibility of a corticosteroid induction regimen trial in juvenile idiopathic arthritis.
In: International Clinical Trials Methodology Conference, 2017-5-8 - 2017-5-10, Liverpool.
Lythgoe, H, Price, V, Beresford, MW, Peak, M and Hawcutt, D ORCID: 0000-0002-8120-6507
(2016)
G90(P) Research exposure for UK junior paediatric trainees.
.
Hawcutt, DB ORCID: 0000-0002-8120-6507, Bellis, J, Price, V, Povall, A, Newland, P, Richardson, P, Peak, M ORCID: 0000-0003-1909-3211 and Blair, J
(2017)
Growth hormone prescribing and initial BMI SDS: Increased biochemical adverse effects and costs in obese children without additional gain in height.
PLoS One, 12 (7).
e0181567-.
Dimou, P, Midgley, A, Peak, M ORCID: 0000-0003-1909-3211, Wright, RD ORCID: 0000-0002-7606-2297 and Beresford, MW ORCID: 0000-0002-5400-9911
(2016)
INVESTIGATING THE NEUTROPHIL-MACROPHAGE INTERPLAY IN JUVENILE LUPUS NEPHRITIS PATHOGENESIS.
.
Oni, L ORCID: 0000-0002-1532-2390, Hawcutt, DB ORCID: 0000-0002-8120-6507, Turner, MA ORCID: 0000-0002-5299-8656, Beresford, MW ORCID: 0000-0002-5400-9911, McWilliam, S ORCID: 0000-0002-0509-7425, Barton, C, Park, BK ORCID: 0000-0001-8384-824X, Murray, P, Wilm, B ORCID: 0000-0002-9245-993X, Copple, I ORCID: 0000-0003-4101-1913 et al (show 4 more authors)
(2017)
Optimising the use of medicines to reduce acute kidney injury in children and babies.
Pharmacology and Therapeutics, 174.
pp. 55-62.
Ramos-Martín, V, Neely, MN, McGowan, P, Siner, S, Padmore, K, Peak, M ORCID: 0000-0003-1909-3211, Beresford, MW ORCID: 0000-0002-5400-9911, Turner, MA ORCID: 0000-0002-5299-8656, Paulus, S ORCID: 0000-0002-0703-9114 and Hope, WW ORCID: 0000-0001-6187-878X
(2016)
Population pharmacokinetics and pharmacodynamics of teicoplanin in neonates: making better use of C-reactive protein to deliver individualized therapy.
The Journal of antimicrobial chemotherapy, 71 (11).
pp. 3168-3178.
Hawcutt, DB ORCID: 0000-0002-8120-6507, Francis, B ORCID: 0000-0002-2130-5976, Carr, D, Jorgensen, AL ORCID: 0000-0002-6977-9337, Yin, P, Wallin, N, O'Hara, NJ, Zhang, JE ORCID: 0000-0003-1813-2207, Bloch, KM, Ganguli, A et al (show 9 more authors)
(2018)
Susceptibility to corticosteroid-induced adrenal suppression: a genome-wide association study.
The Lancet Respiratory Medicine, 6 (6).
pp. 442-450.
Ramos-Martin, V, Neely, MN, Padmore, K, Peak, M ORCID: 0000-0003-1909-3211, Beresford, MW ORCID: 0000-0002-5400-9911, Turner, MA ORCID: 0000-0002-5299-8656, Paulus, S ORCID: 0000-0002-0703-9114, Lopez-Herce, J and Hope, WW ORCID: 0000-0001-6187-878X
(2017)
Tools for the Individualized Therapy of Teicoplanin for Neonates and Children.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 61 (10).
e00707-e00717.
Richey, RH, Hughes, C, Craig, JV, Shah, UU, Ford, JL, Barker, CE, Peak, M ORCID: 0000-0003-1909-3211, Nunn, AJ and Turner, MA ORCID: 0000-0002-5299-8656
(2017)
A systematic review of the use of dosage form manipulation to obtain required doses to inform use of manipulation in paediatric practice.
International Journal of Pharmaceutics, 518 (1-2).
pp. 155-166.